ProfileGDS4718 / 1560199_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 90% 86% 92% 92% 81% 82% 86% 94% 90% 89% 92% 81% 77% 82% 89% 83% 83% 81% 94% 85% 85% 87% 90% 93% 80% 91% 89% 94% 86% 83% 82% 94% 89% 80% 77% 87% 88% 90% 80% 87% 87% 88% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.034594
GSM549102patient 115, normal, homogenized [OPG study]9.2237390
GSM549104patient 119, normal, homogenized [OPG study]8.7001786
GSM549108patient 138, normal, homogenized [OPG study]9.5330292
GSM549119patient 077, normal, homogenized [OPG study]9.6004492
GSM549133patient 032, cancer, homogenized [OPG study]8.0693881
GSM549139patient 042, cancer, homogenized [OPG study]8.1404882
GSM549099patient 107, normal, homogenized [OPG study]8.554886
GSM549109patient 139, normal, homogenized [OPG study]9.9937994
GSM549110patient 046, normal, homogenized [OPG study]9.2580390
GSM549114patient 063, normal, homogenized [OPG study]9.1557489
GSM549122patient 082, normal, homogenized [OPG study]9.5980292
GSM549134patient 033, cancer, homogenized [OPG study]7.9918981
GSM549136patient 036, cancer, homogenized [OPG study]7.6489177
GSM549140patient 044, cancer, homogenized [OPG study]8.2034782
GSM549111patient 047, normal, homogenized [OPG study]9.0414589
GSM549113patient 057, normal, homogenized [OPG study]8.292383
GSM549132patient 031, cancer, homogenized [OPG study]8.2520383
GSM549137patient 038, cancer, homogenized [OPG study]8.0438281
GSM549142patient 047, cancer, homogenized [OPG study]9.5894994
GSM549100patient 110, normal, homogenized [OPG study]8.4633985
GSM549107patient 135, normal, homogenized [OPG study]8.4982785
GSM549115patient 068, normal, homogenized [OPG study]8.9093487
GSM549116patient 072, normal, homogenized [OPG study]9.3372990
GSM549120patient 078, normal, homogenized [OPG study]9.8594693
GSM549131patient 030, cancer, homogenized [OPG study]7.989380
GSM549118patient 074, normal, homogenized [OPG study]9.4659791
GSM549129patient 027, cancer, homogenized [OPG study]8.9388789
GSM549123patient 088, normal, homogenized [OPG study]10.088994
GSM549124patient 006, cancer, homogenized [OPG study]8.5240286
GSM549126patient 015, cancer, homogenized [OPG study]8.1946383
GSM549128patient 025, cancer, homogenized [OPG study]8.1409782
GSM549103patient 117, normal, homogenized [OPG study]9.9567194
GSM549117patient 073, normal, homogenized [OPG study]9.1924589
GSM549138patient 041, cancer, homogenized [OPG study]7.8871480
GSM549141patient 045, cancer, homogenized [OPG study]7.7116777
GSM549130patient 028, cancer, homogenized [OPG study]8.6429887
GSM549101patient 111, normal, homogenized [OPG study]8.8468388
GSM549105patient 128, normal, homogenized [OPG study]9.1745690
GSM549106patient 134, normal, homogenized [OPG study]7.9791480
GSM549112patient 048, normal, homogenized [OPG study]8.8192387
GSM549125patient 011, cancer, homogenized [OPG study]8.6927487
GSM549127patient 024, cancer, homogenized [OPG study]8.8424588
GSM549135patient 035, cancer, homogenized [OPG study]7.5301976